AEON Biopharma Announces Board and Officer Changes
Ticker: AEON · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1837607
| Field | Detail |
|---|---|
| Company | Aeon Biopharma, INC. (AEON) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: AEON
TL;DR
AEON Biopharma shakes up its board and exec comp plans.
AI Summary
AEON Biopharma, Inc. announced on April 3, 2025, a change in its board of directors. Specifically, the company reported the departure of certain directors and the election of new ones, alongside updates to compensatory arrangements for its officers. The filing details these board and executive changes without specifying dollar amounts or new officer appointments.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial priorities, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- AEON Biopharma, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Irvine, CA (location) — Principal executive offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the departure of certain directors and the election of new directors, but does not name the individuals involved or the exact number of changes.
Were there any new officer appointments?
The filing mentions 'Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers' but does not specify any new appointments or name the officers involved.
What is the effective date of these reported changes?
The earliest event reported is dated April 3, 2025, and the filing was made as of April 8, 2025.
Does the filing provide details on new compensatory arrangements?
The filing notes 'Compensatory Arrangements of Certain Officers' but does not provide specific details or dollar amounts regarding these arrangements.
What was AEON Biopharma's former company name?
AEON Biopharma, Inc. was formerly known as Priveterra Acquisition Corp. prior to a name change on December 22, 2020.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding AEON Biopharma, Inc. (AEON).